Results 221 to 230 of about 206,755 (278)

Passive acquisition of hepatitis B virus antibodies after allogeneic hematopoietic cell transplantation

Transfusion, EarlyView.
Abstract Background Newly positive hepatitis B virus (HBV) serologic results after allogeneic hematopoietic cell transplantation (HCT) may reflect passive antibody transfer from blood‐derived products rather than HBV infection. We investigated the incidence and temporal patterns of hepatitis B surface antibody (anti‐HBs) and antibody to hepatitis B ...
Takaaki Konuma, Maki Monna‐Oiwa, Etsuko Nagai, Seiko Kato, Shohei Andoh, Junichi Kuroda, Satoshi Takahashi, Yasuhito Nannya   +7 more
wiley   +1 more source

A retrospective evaluation of responsiveness to platelets in plasma and pathogen‐reduced platelets in platelet additive solution at a single institution

Transfusion, EarlyView.
Abstract Background Studies suggest that recipients of pathogen reduced (PR) platelets in platelet additive solution (PAS) experience inferior increments when compared to platelets in plasma (PS); however, few real‐world studies have confirmed these observations. In this single‐center study, we evaluated responses to PS and PAS/PR platelets in platelet‐
Olivia McClellan, Matthew Najor, Matthew Cusick, Jensyn Cone Sullivan, Laura Cooling, Renad Mohamed, Jennifer M. Jones   +6 more
wiley   +1 more source

Prospective multi‐centre haemovigilance of amotosalen and ultraviolet A‐treated platelets and plasma in routine clinical use

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Amotosalen/ultraviolet A light (A/UVA) pathogen‐reduced platelets and plasma have been approved for clinical use in Europe since 2003 and 2006, respectively. Cross‐sectional safety haemovigilance (HV) studies have been conducted in 29 hospitals in 15 European countries since 2003. This report describes the most recent
Magdalena Łętowska, Anna Krukowska, Dariusz Piotrowski, Zofia Przybylska, Konrad Rosskopf, Angelo Ostuni, Margherita Giannoccaro, Rossella Procacci, Christine Ernst, Johannes Irsch, Laurence Corash, Richard J. Benjamin, Kathy Liu, Linh Dinh, John P. Pitman   +14 more
wiley   +1 more source

Immune platelet transfusion refractoriness associated with anti‐CD36 alloimmunisation in a Brazilian patient with platelet CD36 deficiency

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Immune platelet transfusion refractoriness (PTR) is usually mediated by anti‐HLA class I antibodies; immunisation against CD36 (platelet glycoprotein IV [GPIV]) is relatively rare. Platelet CD36 deficiency shows marked ethnic variability and is seldom reported in admixed Latin American populations.
Rayane Dayse Alves Conserva, Luiz Frederico Bezerra Honorato Junior, Ana Paula Hitomi Yokoyama, Thiago Henrique Costa, Luis Henrique Cardoso Fedeli, Ana Cynira Franco Marret, Eduardo Perez Bastos, Fabio Pires de Souza Santos, Luana Nobrega Costa, Livia Chiosini de Nadai, Carolina Bonet‐Bub, Jose Mauro Kutner   +11 more
wiley   +1 more source

Lifestyle modification in atrial fibrillation: Mechanisms, phenotypes and ablation outcomes

Experimental Physiology, EarlyView.
Abstract Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia and is associated with significant morbidity, mortality and healthcare utilization. Catheter ablation is increasingly used as a rhythm‐control intervention for patients with symptomatic paroxysmal and persistent AF, yet recurrence rates remain suboptimal.
Konstantinos Grigoriou, Paschalis Karakasis, Panagiotis Theofilis, Konstantinos Pamporis, Panayotis K. Vlachakis, Anastasios Apostolos, Nikolaos Ktenopoulos, Barbara Fyntanidou, Efstratios Karagiannidis, Dimitrios Patoulias, Antonios P Antoniadis, Nikolaos Fragakis   +11 more
wiley   +1 more source

Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

Transfusion, EarlyView.
Nabiha H. Saifee, Jennifer Andrews, Mary Berg, Stella T. Chou, Mischa Covington, Elizabeth P. Crowe, Ruchika Goel, Juliana A. Guarente, Tina Ipe, Jeremy W. Jacobs, Jessica Jacobson, Cyril Jacquot, Jenna Khan, Thane A. Kubik, Theodros Mamo, Michael F. Murphy, Kerry O'Brien, Monica B. Pagano, Anil K. Panigrahi, Jacqueline N. Poston, Scott E. Potter, Simon J. Stanworth, Moritz Stolla, Alyssa Ziman, Ryan A. Metcalf   +24 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Definition of Refractoriness to Platelet Transfusions

Transfusion Medicine, 1992
SUMMARY. The relationship between the 1 and 20 h post‐transfusion platelet count and three parameters used to define refractory transfusions, namely the corrected increment (CI), platelet increment (PI), and percentage platelet recovery (%REC), was studied in 437 non‐HLA matched platelet transfusions given to 102 patients with bone marrow failure. The
Jeff Szer, Kally Yuen, J P Matthews
exaly   +3 more sources

Platelet refractoriness in acquired hemophagocytic syndrome

Transfusion, 2011
BACKGROUND:Acquired hemophagocytic syndrome (AHPS) is a severe inflammatory disorder often caused by Epstein‐Barr virus (EBV). Proliferation of activated macrophages produces uncontrolled cytokine production. Thrombocytopenia is common in AHPS, previously attributed to inadequate or ineffective marrow platelet (PLT) production. PLT transfusion response
Melissa R, George, Jay H, Herman, Thomas, Holdbrook, Chunhua, Cui, Harsha G, Vardhana, Eric M, Behling   +5 more
core   +4 more sources